Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE: 000623)

Market Cap	15.50B
Revenue (ttm)	3.28B
Net Income (ttm)	934.16M
Shares Out	1.20B
EPS (ttm)	0.81
PE Ratio	15.93
Forward PE	6.68
Dividend	0.40 (3.07%)
Ex-Dividend Date	Jul 9, 2024

Volume	3,814,055
Open	13.20
Previous Close	13.03
Day's Range	12.93 - 13.20
52-Week Range	12.49 - 17.44
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Jilin Aodong Pharmaceutical Group

Jilin Aodong Pharmaceutical Group Co., Ltd. produces and sells pharmaceutical products in China. The company offers various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It also engages in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 5,646
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000623

Financial Performance

In 2023, Jilin Aodong Pharmaceutical Group's revenue was 3.45 billion, an increase of 20.25% compared to the previous year's 2.87 billion. Earnings were 1.46 billion, a decrease of -18.02%.